MAI Wealth Advisors »

Sab Biotherapeutics shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $436 217 2.01
2025-06-30 $381 217 1.76
2025-03-31 $296 217 1.36
2024-12-31 $494 130 3.80

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Sab Biotherapeutics

Vivo Capital
RA Capital Management
Commodore Capital
Woodline Partners
Sessa Capital IM
BVF
Sphera Funds Management
Vanguard Group
HB Wealth Management
AWM Investment Company
Geode Capital Management
Renaissance Technologies
Pathstone Holdings
Virtu Financial
Kovitz Investment Group Partners

View all funds holding Sab Biotherapeutics